Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegasys + Copegus in Dialysis Patients with Chronic HCV
NCT00491179Phase 4Completed
- Sponsor
- National Taiwan University Hospital
- Start
- Jun 2006
- Primary completion
- Jun 2008
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 4, open-label trial of peginterferon alfa-2a and ribavirin in hepatitis C (HCV), sponsored by National Taiwan University Hospital. Started Jun 2006; status: completed.
02
Drugs
peginterferon alfa-2aribavirin
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00491179.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00491179.